In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
This is the first in a series of three blog posts on aspirin for prevention. It clarifies the potential benefits and harms of aspirin use.
A team of researchers has updated and improved the equations that guide prescribing decisions for physicians in the U.S. regarding cardiovascular risk.
New Stanford Medicine research found that a compound called d-limonene has the potential to help head and neck cancer patients who suffer from dry mouth.
Stanford's David Ouyang sifted through more than a million texts to find out if clinicians inadvertently endorse brand-name medications over less expensive generic alternatives.
Ron Dror and colleagues used computer simulations and lab experiments to better understand G-protein-coupled receptors, which are critical to drug development. In the future, they hope to use this knowledge to design drugs with fewer side effects.
Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.
Stanford scientists have figured out a way to convert common brewer’s yeast into an efficient factory for making a non-narcotic cough medicine that occurs naturally only in opium poppies.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
As part of the "Breaking down diabetes" series, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
In a meta-analysis of more than 500 clinical trials, researchers have new conclusions about the efficacy of 21 different antidepressants.
Stanford's Russ Altman discussed the pharmgkb.org database — which matches genomes with medication information — at the recent Beckman Symposium on campus.